Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis.
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis.
复制标题
DOI:
10.1016/j.metabol.2022.155378
复制
发表时间:
2022-12
期刊:
影响因子:
--
通讯作者:
Shanshan Li;Ze-yuan Lin;Hai-ming Xiao;Zhanchi Xu;Chuting Li;Jing Zeng;Xi Xie;Li Deng;Heqing Huang
中科院分区:
文献类型:
--
作者:
Shanshan Li;Ze-yuan Lin;Hai-ming Xiao;Zhanchi Xu;Chuting Li;Jing Zeng;Xi Xie;Li Deng;Heqing Huang
ObjectiveOxidative stress (OS) is the main cause leading to diabetic renal fibrosis. Recently, Fyn was paid much attention on OS and emerged as a pivotal player in acute kidney injury, while whether Fyn regulates oxidative stress in chronic diabetes nephropathy (DN) has not been clarified yet. The purpose of this study was to identify the role of Fyn in DN and elucidated its regulatory mechanism.MethodsThedb/dbmice and littermate control C57BKS/J mice were injected by tail vein with Fyn interfering adenovirus or Fyn overexpressing adenovirus to investigate the role of Fynin vivo. Primary glomerular mesangial cells (GMCs) were used forin vitrostudies.ResultsFyn was up-regulated in high glucose (HG)-induced GMCs and kidneys of diabetic mice. Additionally, Fyn knockdown reduced the level of OS in HG-induced GMCs and kidneys of diabetic mice, thereby ameliorating diabetic renal fibrosis. While overexpression of Fyn significantly increased the level of OS in GMCs and kidney tissues, resulting in renal damage. Moreover, Fyn deficiency exerted antioxidant effects by activating the Sirt1/Foxo3a pathway. Mechanistically, Fyn facilitated the combination of c-Cbl and Sirt1 by phosphorylating c-Cbl at Tyr731, which triggered K48-linked polyubiquitination of Sirt1 at Lys377and Lys513by c-Cbl and promoted Sirt1 degradation, impairing the antioxidant effects of Foxo3a.ConclusionsFyn deficiency promoted Foxo3a nuclear transcriptionviareducing the ubiquitination of Sirt1 by c-Cbl, thereby alleviating renal oxidative damage in diabetic mice. These results identified Fyn as a potential therapeutic target against DN.